What is the best way to predict IDDM?

Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes

Leonard C. Harrison, Margo C. Honeyman, Henry J. DeAizpurua et al. · The Lancet · 1993 · 245 citations

Medicine, Endocrinology, Immunology +8

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.

William Hagopian, Allan E. Karlsen, Anders Gottsäter et al. · Journal of Clinical Investigation · 1993 · 200 citations · Full text

Life Sciences, Endocrinology, Immunology +17

GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes

Elisabeth Björk, Lı́cio A. Velloso, Olle Kämpe et al. · Diabetes · 1994 · 164 citations

Life Sciences, Endocrinology, Immunology +17

Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement.

Carla J. Greenbaum, Jerry P. Palmer, B. Kuglin et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 147 citations · Full text

Life Sciences, Endocrinology, Internal Medicine +17

Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.

Mark A. Atkinson, D L Kaufman, Diane K. Newman et al. · Journal of Clinical Investigation · 1993 · 127 citations · Full text

Life Sciences, Endocrinology, Immunology +17